Showing results (1531-1540 of 1,911) with videos related to
Sort By:
Pageof 192
Nature Chemical Biology|January 27, 2026
Tau phosphorylation impedes functionality of protective tau envelopesValerie Siahaan, Romana Weissova, Adela Karhanova, et al.Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|April 3, 2015
Clinical investigation into feed-related hypervitaminosis D in a captive flock of budgerigars (Melopsittacus undulatus): morbidity, mortalities, and pathologic lesionsJune E Olds, Eric Burrough, Darin Madison, et al.Journal of Personalized Medicine|May 25, 2024
A Grounded Theory of Interdisciplinary Communication and Collaboration in the Outpatient Setting of the Hospital for Patients with Multiple Long-Term ConditionsEmma A Gans, Ursula W de Ruijter, Agnes van der Heide, et al.Faraday Discussions|May 30, 2018
Insights into structure and dynamics of (Mn,Fe)Ox-promoted Rh nanoparticlesMaria Dimitrakopoulou, Xing Huang, Jutta Kröhnert, et al.Journal of Clinical Microbiology|October 2, 2009
Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profilesJoep de Bruijne, Janke Schinkel, Maria Prins, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 10, 2017
Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM)Astrid M Newsum, Ineke G Stolte, Jan Tm van der Meer, et al.Toxicologic Pathology|January 27, 2010
Incisor degeneration in rats induced by vascular endothelial growth factor/fibroblast growth factor receptor tyrosine kinase inhibitionAnthony M Fletcher, Carla L Bregman, Jochen Woicke, et al.Gut|October 24, 2025
Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohortAna Luz Chumbe, Suzanne M D van den Aardweg, Anders Boyd, et al.Blood|September 19, 2013
Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemiaEric I Zimmerman, David C Turner, Jassada Buaboonnam, et al.Cell Reports|October 8, 2013
Protective roles for caspase-8 and cFLIP in adult homeostasisRicardo Weinlich, Andrew Oberst, Christopher P Dillon, et al.Pageof 192